PULM
HEALTHCAREPulmatrix Inc
$1.36+0.00 (+0.00%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PULM Today?
No stock-specific AI insight has been generated for PULM yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.16$9.37
$1.36
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-1.41
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin—
Debt / Equity—
Trading
Volume12K
Avg Volume (10D)—
Shares Outstanding3.7M
PULM News
10 articles- Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned MergerYahoo Finance·Apr 21, 2026
- Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve HealthspanYahoo Finance·Mar 26, 2026
- Wave crashes on obesity drug update; Kodiak’s reboot pays dividendsBiopharmadive·Mar 26, 2026
- Gyre Therapeutics to acquire Cullgen in $300M all-stock transactionYahoo Finance·Mar 3, 2026
- Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger OpportunitiesYahoo Finance·Mar 2, 2026
- Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial ResultsYahoo Finance·Feb 26, 2026
- Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore AlternativesYahoo Finance·Dec 18, 2025
- Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation AssetsYahoo Finance·Oct 16, 2025
- Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation AssetsYahoo Finance·Aug 6, 2025
- Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for AssetsYahoo Finance·May 15, 2025
All 10 articles loaded
Price Data
Open$1.27
Previous Close$1.36
Day High$1.31
Day Low$1.26
52 Week High$9.37
52 Week Low$1.16
52-Week Range
$1.16$9.37
$1.36
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-1.41
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin—
Debt / Equity—
Trading
Volume12K
Avg Volume (10D)—
Shares Outstanding3.7M
About Pulmatrix Inc
Pulmatrix, Inc., a clinical-stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company is headquartered in Lexington, Massachusetts.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—